Plain-English translation of NCT06589505 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 3 — Testing in thousands of people, comparing the treatment against what doctors currently use. This is the last big step before approval.
This is a research study testing a new software program designed to help people who have PTSD—a condition that can develop after experiencing or witnessing a traumatic event. Researchers want to see if this software treatment is safe and effective at reducing PTSD symptoms. About 52 people will participate across multiple centers.
Many people with PTSD struggle to find effective treatment or may not have access to trauma-focused therapy. This trial explores whether a software-based tool could offer a new way to help people heal from their trauma.
You likely qualify if…
You likely don't qualify if…
If you join this study, you will be randomly placed into one of two groups—both will use the software treatment, though they may differ slightly in how they work. You'll visit the research center multiple times to use the software and have your progress checked. The study team will monitor how you're doing and whether the treatment is helping reduce your PTSD symptoms over time.
AI-generated summary from trial data · Jun 11, 2026 · Not medical advice
Japan